경영·경제 질문은 AI 비서에게,
무엇이든 물어보세요.
로그인 후 질문을 입력해주세요
소개영상보기
Public Health
Hair Loss Recognized as Disease from Follicle Damage
In recent academic discourse, there is growing recognition of hair loss as a disease of modern people. Getty Images Bank After President Lee Jae-myung stated during the Ministry of Health and Welfare’s year-end 2025 policy briefing that “hair loss is a matter of survival,” controversy has reignited in political circles over whether hair loss treatment should be covered by the National Health Insur
2026.02.02
MedTech
Celltrion Internalizes Hyaluronidase SC Formulation Technology
2026.02.02
MedTech
OLED “Hair-Loss Cap” Claims 92% Cell Aging Cut
2026.02.01
MedTech
Korean Team Develops Light-Based Cancer Cell Therapy
2026.02.06
Global Business
Korea United Pharm speeds Vietnam push, targets double cancer drug sales
2026.02.05
Recent Articles
-
Medical / ResearchHealth Capsule: Yonsei Med School Reveals Immune Control Mechanism■ Yonsei University College of Medicine identifies principles of immune response regulation From left, Professor Hyungpyo Kim, Professor Eunchong Lee A study has found that the three-dimensional structure of the genome directly affects the functioning of immune genes and drug responses. A research t2026.01.14 -
MedTechSimple blood test detects cancer earlierCha Jae-myung, Director of the Health Promotion Center at Kyung Hee University Hospital at Gangdong, forecasts a shift from tissue biopsy, which diagnoses cancer through tissue sampling, to liquid biopsy, which can diagnose cancer through blood tests. He also expects that liquid biopsy technology wi2026.01.14 -
MedTechSiji MedTech Completes China Trial, Targets Market with JishuitanCG MedTech (CEO Yoo Hyun-seung), a company specializing in the research and manufacture of in-body implants, announced that it has completed the clinical evaluation in China for its magnesium-based absorbable orthopedic implant “Resomet” and will begin full-scale preparations for approval by China’s2026.01.14 -
AI BiotechNvidia, Lilly Deal Spurs AI Alliances in BiotechKimberly Powell, Vice President of Healthcare & Life Sciences at NVIDIA, announced on the 12th (local time) at the “JP Morgan Healthcare Conference” held at the Westin St. Francis Hotel in San Francisco, USA, that the company will establish an “AI Joint Innovation Lab” with Eli Lilly. Provided by NV2026.01.14 -
NvidiaNvidia, Eli Lilly Join Forces on AI Bio InnovationKimberly Powell, Vice President of Healthcare and Life Sciences at NVIDIA, announced on the 12th (local time) during the corporate presentation session at the “J.P. Morgan Healthcare Conference” held at the Westin St. Francis Hotel in San Francisco, United States, that NVIDIA will establish an “AI J2026.01.13 -
Pharmaceutical R&DCelltrion Faces 2026 Turning Point, Eyes High-Margin EraCelltrion Biologics Research Center With the arrival of 2026, the Year of Byeongo (丙午年), Celltrion’s earnings structure is facing a major turning point. The company is moving away from a revenue structure centered on the so‑called “three flagship products” (Remsima, Truxima, Herzuma), which have dri2026.01.12 -
Investment Trend / K-BioK-Bio Firms Flock to World’s Largest Investor EventPhoto source = pixabay The JP Morgan Healthcare Conference (JPMHC), the world’s largest investment event in the pharmaceutical and biotech industry, will be held in San Francisco, United States, from the 12th to the 15th of this month (local time). As the total value of technology exports by domesti2026.01.12 -
MedTechBainotech’s ‘Daehansammac’ Red Ginseng Tech Draws CES 2026 AttentionPhoto provided by Vinotech Tech-bio company Vinotech Co., Ltd. received evaluations that its premium red ginseng product “Daehansammac,” unveiled at “CES 2026” in Las Vegas, United States, demonstrated differentiation in the way products and technologies are applied, compared with those of global bi2026.01.11 -
CES 2026 / AI healthcareAt CES, Pixelro Proves Eye Health Self-Diagnosis TechAI healthcare solutions company PIXELRO announced that its AI eye health self-diagnosis solution has been designated as an Innovation Product at CES 2026, the world’s largest technology industry exhibition.At this year’s CES, PIXELRO showcased eye health self-diagnosis and self-testing solutions for2026.01.10 -
MedTechCGBio CEO Yoo Hyun-seung Named SNU Innovation 50Yu Hyun-seung, CEO of CG Bio. Biotech company CG Bio announced on the 9th that CEO Yu Hyun-seung has been named one of the “50 Innovative Alumni of the College of Engineering from Gwanak” selected by the College of Engineering at Seoul National University.According to CG Bio, the selection took into2026.01.09
